Enovis Corporation (ENOV)

NYSE: ENOV · USD

$21.8

+0.30 (+1.4%)· Recorded snapshot

Market cap	1.3B
Revenue (ttm)	2.3B
Net income (ttm)	-1.1B
EPS (ttm)	-$19.2
Shares out	57.7M
P/E (forward)	6.2x
Volume	916,507
Beta	1.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.3B
Net income (ttm): -1.1B
EPS (ttm): -$19.2
P/E (forward): 6.2x
Market cap: 1.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E6.2

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-54.1

P25 n/aP50 n/aP75 n/a

ROIC3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ENOV indicators

Market & fundamental data

Available fields

249

Groups with data

Currency

USD

Showing 249 of 249 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001420800
Company name	Enovis Corporation
Country	United States
Country code	US
CUSIP number	194014502
Earnings date	2026-11-05
Earnings time	bmo
Employees	7,802
Employees change	435
Employees growth	5.9%
Enterprise value	$2.6B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-07-03
First seen	2026-05-09
Fiscal year end	December
Founded	1995
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2008-05-08
Is primary listing	Yes
Is SPAC	No
ISIN number	US1940145022
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2022-04-05
Last stock split type	Reverse
Market cap	$1.3B
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$21.84
Price currency	USD
Sector	Healthcare
SIC code	3842
Stock price date	2026-10-28
Symbol	ENOV
U.S. state	Texas
Website	https://www.enovis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	6.26x
Earnings yield	-88.01%
EV/EBIT	31.22x
EV/EBITDA	6.9x
EV/FCF	41.19x
EV/Sales	1.14x
FCF / EV yield	2.43%
FCF yield	5.03%
Forward EV/Sales	1.09x
Forward P/E	6.19x
Forward P/S	0.53x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/(FCF - SBC) ratio	43.51x
P/(OCF - SBC) ratio	5.37x
P/B ratio	0.84x
P/FCF ratio	19.88x
P/OCF ratio	4.69x
P/S ratio	0.55x
PEG ratio	0.89x
Price/EBITDA ratio	3.33x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	3.66%
EBITDA margin	16.54%
FCF margin	2.77%
Gross margin	61.32%
Operating margin	3.66%
Pretax margin	-46.52%
Profit margin	-47.97%
Profit per employee	$-141,206
Revenue per employee	$294,361
ROA	1.19%
ROA (5Y)	0.42%
ROCE	2.66%
ROE	-54.14%
ROE (5Y)	-18.18%
ROIC	2.95%
ROIC (5Y)	0.82%
SBC / revenue	1.51%
Tax / revenue	1.34%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	0
FCF growth (Q)	815.79%
FCF growth 5Y	-24.67%
Gross profit growth	6.69%
Gross profit growth (Q)	5.38%
Gross profit growth 3Y	14.22%
Gross profit growth 5Y	5.56%
Net income growth quarters	3
Net income growth years	0
OCF growth	43.63%
OCF growth (Q)	57.07%
OCF growth (QoQ)	213.27%
OCF growth 10Y	-0.82%
OCF growth 3Y	142.2%
OCF growth 5Y	-6.17%
Operating income growth	-16.15%
Operating income growth (Q)	44.02%
Operating income growth 5Y	-7.6%
Revenue growth	4.89%
Revenue growth (Q)	3.23%
Revenue growth (QoQ)	-1.08%
Revenue growth 10Y	-4.49%
Revenue growth 3Y	12.17%
Revenue growth 5Y	-0.04%
Revenue growth quarters	17
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-206.4M
Depreciation and amortization	$295.8M
EBIT	$84M
EBITDA	$379.8M
EPS	$-19.22
FCF per share	$1.10
Financing cash flow	$-134.4M
Free cash flow	$63.7M
Free cash flow minus SBC	$29.1M
Gross profit	$1.4B
Income taxes	$30.8M
Investing cash flow	$-167.2M
Net borrowing	$-113.9M
Net cash flow	$-31.5M
Net income	$-1.1B
Operating cash flow minus SBC	$235.5M
Operating income	$84M
Revenue	$2.3B
Stock-based compensation	$34.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.73
Book value per share	$25.61
Debt / EBITDA	3.4
Debt / equity	0.93
Debt / FCF	21.51
Goodwill	$709.9M
Interest coverage	1.07
Long-term assets	$2.6B
Long-term liabilities	$1.7B
Net cash (debt)	$-1.4B
Net cash / market cap	-107.16%
Net debt / EBITDA	3.57
Net debt / equity	0.92
Net debt / FCF	21.31
Piotroski F-Score	6
Property, plant and equipment	$602.4M
Shareholders' equity	$1.5B
Tangible book value	$-383.1M
Tangible book value per share	$-6.64
Total assets	$3.8B
Total cash	$12.6M
Total debt	$1.4B
Total liabilities	$2.3B
WACC	8.32%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.52
Current assets	$1.2B
Current liabilities	$612.1M
Current ratio	1.98
Inventory turnover	1.44
Net working capital	$652.8M
Quick ratio	0.74
Working capital	$602.6M
Working capital turnover	3.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.67%
Dividend yield	0%
Shareholder yield	-1.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-77.3%
10Y return CAGR	-8.85%
10Y total return	-60.41%
150-day SMA	$23.09
15Y price change	-69.38%
15Y return CAGR	-4.09%
15Y total return	-46.59%
1D price change	1.39%
1M price change	18.09%
1M total return	18.09%
1W price change	5.37%
1W total return	5.37%
1Y price change	-33.66%
1Y return CAGR	-33.68%
1Y total return	-33.66%
20-day SMA	$19.44
200-day SMA	$23.10
3M price change	-22.83%
3M total return	-22.83%
3Y price change	-51.19%
3Y return CAGR	-21.26%
3Y total return	-51.19%
50-day SMA	$20.20
50-day SMA vs 200-day SMA	50under200
52-week high	$33.13
52-week high date	2025-10-29
52-week low	$16.70
52-week low date	2026-10-08
5Y price change	-85.66%
5Y return CAGR	-24.21%
5Y total return	-74.99%
6M price change	-11.17%
6M total return	-11.17%
All-time high	$226.11
All-time high date	2014-06-09
All-time low	$15.99
All-time low date	2009-03-09
Average true range (ATR)	$0.93
Average volume	1.2M
Beta (1Y)	1.02
Beta (2Y)	1.37
Beta (5Y)	1.48
Change from 52-week high	-34.08%
Change from 52-week low	30.78%
Change from all-time high	-90.36%
Change from all-time low	36.34%
Change from open	1.82%
Day's gap	-0.42%
Dollar volume	$20M
High price	$22.25
Low price	$21.45
Monthly RSI	39.35
Open price	$21.45
Position in 52-week range	48.75%
Premarket change	-1.58%
Premarket close	$21.54
Premarket price	$21.20
Premarket volume	358
Previous close	$21.54
Price vs 150-day SMA	-5.57%
Price vs 20-day SMA	12.16%
Price vs 200-day SMA	-5.64%
Price vs 50-day SMA	7.9%
Relative volume	0.73
RSI	65.06
Sharpe ratio	-0.39
Sharpe ratio (3Y)	-0.34
Sharpe ratio (5Y)	-0.52
Sortino ratio	-0.46
Sortino ratio (3Y)	-0.37
Sortino ratio (5Y)	-0.6
Volume	916.5K
Weekly RSI	47.97
YTD price change	-18.17%
YTD total return	-18.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52.8M
Float percentage	91.49%
Shares change (QoQ)	0.5%
Shares change (YoY)	1.67%
Shares held by insiders	1.72%
Shares held by institutions	112.51%
Shares outstanding	57.7M
Short % of float	20.02%
Short % of shares	18.31%
Short ratio	4.9 days

Deeper analysis on ENOV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ENOV report

Is a complete ENOV research report available?

No complete published report is available for Enovis Corporation (ENOV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Enovis Corporation (ENOV)

Price

Financial snapshot

Fair-value bridge

Latest news · ENOV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ENOV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ENOV

Frequently asked questions